Rockland Trust Co. Boosts Stock Position in West Pharmaceutical Services, Inc. (NYSE:WST)
Rockland Trust Co. Boosts Stock Position in West Pharmaceutical Services, Inc. (NYSE:WST)
Rockland Trust Co. increased its stake in shares of West Pharmaceutical Services, Inc. (NYSE:WST – Get Rating) by 3,699.4% in the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 48,404 shares of the medical instruments supplier's stock after purchasing an additional 47,130 shares during the quarter. Rockland Trust Co.'s holdings in West Pharmaceutical Services were worth $14,636,000 as of its most recent filing with the Securities and Exchange Commission.
Rockland Trust Co.在最近提交给美国证券交易委员会的13F文件中称,该公司在第二季度增持了West Pharmtics Services,Inc.(纽约证券交易所代码:WST-GET评级)股票3,699.4%。该机构投资者在本季度额外购买了47,130股票后,持有这家医疗器械供应商的股票48,404股。截至最近提交给美国证券交易委员会的文件,罗克兰信托公司在West Pharmtics Services的持股价值为14,636,000美元。
A number of other hedge funds have also recently added to or reduced their stakes in WST. Allworth Financial LP lifted its stake in shares of West Pharmaceutical Services by 140.0% in the 1st quarter. Allworth Financial LP now owns 72 shares of the medical instruments supplier's stock valued at $30,000 after purchasing an additional 42 shares in the last quarter. Addison Advisors LLC lifted its stake in shares of West Pharmaceutical Services by 221.7% in the 1st quarter. Addison Advisors LLC now owns 74 shares of the medical instruments supplier's stock valued at $30,000 after purchasing an additional 51 shares in the last quarter. Artemis Wealth Advisors LLC acquired a new position in shares of West Pharmaceutical Services in the 1st quarter valued at about $35,000. American National Bank lifted its stake in shares of West Pharmaceutical Services by 55.6% in the 1st quarter. American National Bank now owns 98 shares of the medical instruments supplier's stock valued at $40,000 after purchasing an additional 35 shares in the last quarter. Finally, Dividend Assets Capital LLC acquired a new position in shares of West Pharmaceutical Services in the 4th quarter valued at about $51,000. 91.98% of the stock is owned by institutional investors and hedge funds.
其他一些对冲基金最近也增持或减持了WST的股份。Allworth Financial LP在第一季度增持了140.0%的西方制药服务公司的股份。Allworth Financial LP在上个季度额外购买了42股后,现在拥有这家医疗器械供应商72股股票,价值3万美元。Addison Advisors LLC在第一季度增持了221.7%的西部药业股份。Addison Advisors LLC在上个季度购买了51股后,现在拥有74股这家医疗器械供应商的股票,价值3万美元。Artemis Wealth Advisors LLC在第一季度收购了西方制药服务公司的新股份,价值约3.5万美元。美国国家银行在第一季度增持了西方制药服务公司的股份55.6%。美国国民银行现在持有这家医疗器械供应商98股股票,价值40,000美元,上个季度又购买了35股。最后,红利资产资本有限责任公司在第四季度收购了西部制药服务公司的新股票,价值约为5.1万美元。91.98%的股票由机构投资者和对冲基金持有。
Insiders Place Their Bets
内部人士下注
In other West Pharmaceutical Services news, insider Silji Abraham sold 5,374 shares of West Pharmaceutical Services stock in a transaction that occurred on Monday, August 1st. The stock was sold at an average price of $343.93, for a total transaction of $1,848,279.82. Following the sale, the insider now directly owns 3,201 shares in the company, valued at approximately $1,100,919.93. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. 0.60% of the stock is owned by company insiders.
在其他西方制药服务公司的消息中,内部人士Silji Abraham在8月1日星期一的一笔交易中出售了5,374股西方制药服务公司的股票。股票以343.93美元的平均价格出售,总成交金额为1,848,279.82美元。出售后,这位内部人士现在直接拥有该公司3,201股,价值约1,100,919.93美元。这笔交易是在提交给美国证券交易委员会的一份文件中披露的,该文件可通过美国证券交易委员会网站获得。公司内部人士持有该公司0.60%的股份。
West Pharmaceutical Services Trading Down 2.1 %
西部医药服务公司股价下跌2.1%
West Pharmaceutical Services (NYSE:WST – Get Rating) last released its quarterly earnings results on Thursday, July 28th. The medical instruments supplier reported $2.47 EPS for the quarter, topping the consensus estimate of $2.19 by $0.28. The firm had revenue of $771.30 million for the quarter, compared to analyst estimates of $754.25 million. West Pharmaceutical Services had a return on equity of 29.08% and a net margin of 23.41%. West Pharmaceutical Services's revenue for the quarter was up 6.6% on a year-over-year basis. During the same period in the previous year, the company posted $2.46 EPS. On average, analysts predict that West Pharmaceutical Services, Inc. will post 9.09 earnings per share for the current year.
West Pharmtics Services(纽约证券交易所代码:WST-GET Rating)最近一次发布季度收益报告是在7月28日星期四。这家医疗器械供应商公布本季度每股收益为2.47美元,比普遍预期的2.19美元高出0.28美元。该公司本季度营收为7.713亿美元,而分析师预期为7.5425亿美元。西部医药服务公司的股本回报率为29.08%,净利润率为23.41%。West Pharmtics Services本季度的收入同比增长了6.6%。去年同期,该公司公布的每股收益为2.46美元。分析师平均预测,West Pharmtics Services,Inc.本年度每股收益将达到9.09美元。
West Pharmaceutical Services Profile
西部药业服务简介
(Get Rating)
(获取评级)
West Pharmaceutical Services, Inc designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Proprietary Products and Contract-Manufactured Products.
西方制药服务公司在美洲、欧洲、中东、非洲和亚太地区设计、制造和销售可注射药物和保健产品的容器和输送系统。它分为两个部分,专有产品和合同制造产品。
Read More
阅读更多内容
- Get a free copy of the StockNews.com research report on West Pharmaceutical Services (WST)
- Has AMD stock stock fallen too far?
- Oracle's Short-Term Pain Could Be Your Long-Term Gain
- Lucid is Looking Like a Clear EV Winner
- Still Lovin' It: Investors Keep Visiting McDonald's
- Did FedEx Just Deliver A Buying Opportunity?
- 免费获取StockNews.com关于West Pharmtics Services(WST)的研究报告
- AMD股票是不是跌得太厉害了?
- 甲骨文的短期痛苦可能是你的长期收益
- Lucid看起来像是电动汽车的赢家
- 仍然爱着它:投资者继续光顾麦当劳
- 联邦快递刚刚提供了一个买入机会吗?
Want to see what other hedge funds are holding WST? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for West Pharmaceutical Services, Inc. (NYSE:WST – Get Rating).
想看看还有哪些对冲基金持有WST吗?访问HoldingsChannel.com获取西方制药服务公司(纽约证券交易所代码:WST-GET Rating)的最新13F文件和内幕交易。
Receive News & Ratings for West Pharmaceutical Services Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for West Pharmaceutical Services and related companies with MarketBeat.com's FREE daily email newsletter.
接受《西部医药服务报》的新闻和评级-在下面输入您的电子邮件地址,通过MarketBeat.com的免费每日电子邮件时事通讯接收对West Pharmtics Services和相关公司的最新新闻和分析师评级的每日简要摘要。